130 related articles for article (PubMed ID: 30235493)
1. Altered TEG Parameters Identify Hypercoagulablilty and are of Diagnosis Value for Papillary Thyroid Carcinoma Patients.
Lu S; Kang R; Wang Y; Zhu M; Zhao L; Xu Q; Song Y; Liu C
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):297-302. PubMed ID: 30235493
[TBL] [Abstract][Full Text] [Related]
2. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer.
Klimaite R; Kazokaite M; Kondrotiene A; Dauksiene D; Verkauskiene R; Zilaitiene B; Dauksa A
Anticancer Res; 2022 May; 42(5):2289-2299. PubMed ID: 35489725
[TBL] [Abstract][Full Text] [Related]
4. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
6. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
7. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.
Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S
Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982
[TBL] [Abstract][Full Text] [Related]
8. Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE.
Wu Z; Guo M; Yang J; Xiao Y; Liu W
Medicine (Baltimore); 2022 Jun; 101(24):e29402. PubMed ID: 35713446
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas.
Baldane S; Ipekci SH; Sozen M; Kebapcilar L
Asian Pac J Cancer Prev; 2015; 16(7):2671-4. PubMed ID: 25854344
[TBL] [Abstract][Full Text] [Related]
10. Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma.
Zhou Z; Zhang J; Jiang F; Xie Y; Zhang X; Jiang L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28684549
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
[TBL] [Abstract][Full Text] [Related]
12. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
[TBL] [Abstract][Full Text] [Related]
13. A comparison of haemogram parameters of patients with thyroid papillary cancer and nodular goiter in Van, Turkey.
Yildiz S; Eker E; Ozturk M; Alay M
J Pak Med Assoc; 2019 Nov; 69(11):1642-1646. PubMed ID: 31740871
[TBL] [Abstract][Full Text] [Related]
14. Thromboelastography Parameters Change Significantly in Patients with Endometrial Cancer and Uterine Fibroids.
Lu S; Gao W; Li M; Xu Q; Rong J; Song Y; Liu C
Clin Lab; 2023 Mar; 69(3):. PubMed ID: 36912292
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.
Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B
Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270
[TBL] [Abstract][Full Text] [Related]
16. [
Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
[No Abstract] [Full Text] [Related]
17. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
18. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
[TBL] [Abstract][Full Text] [Related]
19. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma.
Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S
Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870
[TBL] [Abstract][Full Text] [Related]
20. [Application value of thromboelastography in patients with multiple trauma in emergency department].
Qu Q; Wei X; Hou J; Yang R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):623-628. PubMed ID: 31198152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]